MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Spectral AI Stock

Spectral AI, Inc.

MDAINASDAQMarkt
US$1.51
-1.9% today

Company data

Sector
Healthcare
Industry
Medical - Specialties
Country
United States
CEO
Vincent S. Capone
Employees
65
Market cap
$49 M
IPO
06/04/2021

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked…

Spectral AI stock: price history

16/10/25-38.6 %16/10/26

1D

-1.9%

1W

-8.5%

1M

-2.6%

6M

-20.1%

YTD

+6.3%

1Y

-38.6%

2Y

+17.1%

5Y

-84.5%

10Y

–

Next earnings date

Next earnings date

10/11/2026 (in 24 days)

Volatility around earnings

~12% weaker price swings than usual

Pattern chart

Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 14/10/26. Not a buy or sell signal.Beta

What does this mean?

Volatility squeeze

Bearish

Price swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.

Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.

Ask the agents about Spectral AI

Analyst assessment of Spectral AI

PRICE TARGET LOW

US$4.00

CONSENSUS

US$4.00

MEDIAN

US$4.00

PRICE TARGET HIGH

US$4.00

0

STRONG BUY

2

BUY

0

HOLD

0

SELL

0

STRONG SELL

2

TOTAL · Buy

As of: 27/05/2026

ANALYST FIRMRATINGACTIONDATE
BTIGBuymaintain27/05/2026
BTIGBuymaintain26/05/2026
BTIGBuymaintain25/03/2026
BTIGBuymaintain10/02/2026
BTIGBuymaintain12/11/2025
HC Wainwright & Co.Buymaintain02/04/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain18/03/2025 (older than 12 months)
HC Wainwright & Co.Buymaintain13/08/2024 (older than 12 months)

Spectral AI stock metrics

P/E

-4.33

P/B

-4.02

EV/EBITDA

-6.22

RETURN ON EQUITY

34.6%

NET MARGIN

-118.5%

DEBT/EQUITY

-1.35

DIVIDEND YIELD

0.0%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

71.5%

FLOAT SHARES

23,002,708

AVG. DAILY VOLUME (30D)

134,001

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

DiMaio John Michael

DirectorGrant32,0001.62Spontaneous29/09/2026

DiMaio John Michael

DirectorGrant60,0001.67Spontaneous25/09/2026

DiMaio John Michael

DirectorGrant21,0121.69Spontaneous21/09/2026

DiMaio John Michael

DirectorGrant10,9881.61Spontaneous21/09/2026

DiMaio John Michael

DirectorGrant10,0001.56Spontaneous14/09/2026
Page 1 / 5

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
VANGUARD CAPITAL MANAGEMENT LLC994,410+268,12030/06/2026
Highlander Partners, L.P.900,000+030/06/2026
MARSHALL WACE, LLP827,454+827,45430/06/2026
BRIDGEWAY CAPITAL MANAGEMENT, LLC287,000+88,00030/06/2026
JANE STREET GROUP, LLC226,319+5,31830/06/2026
Page 1 / 3

Comparable stocks

Frequently asked questions about Spectral AI stock

What does Spectral AI do?

Spectral AI, Inc. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.

The CEO is Vincent S. Capone, the company employs around 65 people.

The IPO was on 06/04/2021; the stock trades on NASDAQ under the ticker MDAI.

What do analysts say about Spectral AI stock?

2 analysts rate the stock, the consensus is Buy (as of 27/05/2026).

The average price target is US$4.00, ranging from US$4.00 to US$4.00, with a median of US$4.00.

This is an external assessment, not a statement by Market Jury.

When does Spectral AI report next?

The next earnings date is 10/11/2026.

Around past earnings, price swings were roughly -12% stronger than usual.

Does Spectral AI pay a dividend?

No, Spectral AI currently does not pay a dividend.

Which stocks are comparable to Spectral AI?

Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson and AbbVie.

How can I get Spectral AI stock analyzed?

Clicking "Analyze stock" lets five strategies assess Spectral AI against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.